This is a StreetInsider.com Premium Only Page

Eiger BioPharmaceuticals (EIGR) –

Apr 25, 2024 09:11 AM Form 25-NSE Eiger BioPharmaceuticals Filed by: Nasdaq Stock Market LLC

Apr 8, 2024 05:20 PM Form 10-K Eiger BioPharmaceuticals For: Dec 31

Apr 3, 2024 04:47 PM Eiger BioPharmaceuticals (EIGR) to Be Delisted from Nasdaq

Apr 3, 2024 04:45 PM Form 8-K Eiger BioPharmaceuticals For: Apr 01

Apr 1, 2024 05:01 PM Form NT 10-K Eiger BioPharmaceuticals For: Dec 31

Apr 1, 2024 04:59 PM Form S-8 POS Eiger BioPharmaceuticals

Apr 1, 2024 04:57 PM Form S-8 POS Eiger BioPharmaceuticals

Apr 1, 2024 04:56 PM Form S-8 POS Eiger BioPharmaceuticals

Apr 1, 2024 04:55 PM Form S-8 POS Eiger BioPharmaceuticals

Apr 1, 2024 04:54 PM Form S-8 POS Eiger BioPharmaceuticals

Apr 1, 2024 04:52 PM Form S-8 POS Eiger BioPharmaceuticals

Apr 1, 2024 04:51 PM Form S-8 POS Eiger BioPharmaceuticals

Apr 1, 2024 04:49 PM Form S-8 POS Eiger BioPharmaceuticals

Apr 1, 2024 04:49 PM Form S-8 POS Eiger BioPharmaceuticals

Apr 1, 2024 04:46 PM Form S-8 POS Eiger BioPharmaceuticals

Apr 1, 2024 04:46 PM Form S-8 POS Eiger BioPharmaceuticals

Apr 1, 2024 04:18 PM Form 8-K Eiger BioPharmaceuticals For: Mar 31

Apr 1, 2024 11:13 AM Eiger BioPharmaceuticals (EIGR) Files Chapter 11

Apr 1, 2024 11:12 AM Eiger BioPharmaceuticals Files for Voluntary Chapter 11 Protection

Mar 11, 2024 04:03 PM Form 8-K Eiger BioPharmaceuticals For: Mar 08

Feb 14, 2024 04:06 PM Form SC 13G/A Eiger BioPharmaceuticals Filed by: 683 Capital Management, LLC

Feb 14, 2024 10:56 AM Form SC 13G/A Eiger BioPharmaceuticals Filed by: AMERIPRISE FINANCIAL INC

Jan 24, 2024 05:11 PM Eiger BioPharmaceuticals (EIGR) Announces Resignation of Chief Commercial Officer

Jan 24, 2024 05:00 PM Form 8-K Eiger BioPharmaceuticals For: Jan 18

Jan 18, 2024 06:05 PM Eiger (EIGR) and AnGes Receive Approval for Zokinvy for Hutchinson-Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies in Japan

Jan 18, 2024 05:49 PM Eiger and Partner, AnGes, Receive Approval for Zokinvy® (lonafarnib) for Hutchinson- Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies in Japan

Jan 8, 2024 07:01 AM Form 8-K Eiger BioPharmaceuticals For: Jan 05

Jan 4, 2024 08:46 AM Form 8-K Eiger BioPharmaceuticals For: Dec 28

Jan 4, 2024 08:01 AM Eiger BioPharmaceuticals (EIGR) Announces 1:30 Reverse Share Split

Jan 4, 2024 08:00 AM Eiger BioPharmaceuticals, Inc. Announces 1-for-30 Reverse Stock Split

Dec 11, 2023 04:02 PM Form DEF 14A Eiger BioPharmaceuticals For: Dec 28

Dec 4, 2023 06:04 AM Form SC 13D/A Eiger BioPharmaceuticals Filed by: Arkin Moshe

Dec 1, 2023 04:03 PM Form PRE 14A Eiger BioPharmaceuticals For: Dec 28

Nov 24, 2023 06:01 AM Form SC 13D Eiger BioPharmaceuticals Filed by: Arkin Moshe

Nov 13, 2023 04:02 PM Form 8-K Eiger BioPharmaceuticals For: Nov 10

Nov 13, 2023 08:30 AM Cutera Appoints Stephana Patton as Chief Legal Officer

Nov 9, 2023 04:29 PM Form 10-Q Eiger BioPharmaceuticals For: Sep 30

Nov 9, 2023 04:24 PM Eiger BioPharmaceuticals (EIGR) Misses Q3 EPS by 10c

Nov 9, 2023 04:16 PM Form 8-K Eiger BioPharmaceuticals For: Nov 09

Nov 9, 2023 04:05 PM Eiger BioPharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update

Nov 3, 2023 06:05 AM Form SC 13D/A Eiger BioPharmaceuticals Filed by: Propel Bio Management, LLC

Nov 2, 2023 09:22 PM Form 4 Eiger BioPharmaceuticals For: Oct 31 Filed by: KAYNE RICHARD A

Nov 2, 2023 09:15 PM Form 4 Eiger BioPharmaceuticals For: Oct 31 Filed by: KAWAS LEEN

Oct 30, 2023 04:54 PM Form 3 Eiger BioPharmaceuticals For: Oct 18 Filed by: KAYNE RICHARD A

Oct 30, 2023 04:52 PM Form 3 Eiger BioPharmaceuticals For: Oct 18 Filed by: KAWAS LEEN

Oct 20, 2023 04:29 PM Form SC 13D Eiger BioPharmaceuticals Filed by: Propel Bio Management, LLC

Sep 28, 2023 04:55 PM Form SC 13G/A Eiger BioPharmaceuticals Filed by: Propel Bio Management, LLC

Sep 12, 2023 04:42 PM Form 8-K Eiger BioPharmaceuticals For: Sep 12

Sep 12, 2023 04:05 PM Eiger BioPharmaceuticals (EIGR) to Discontinue Phase 3 LIMT-2 Trial of Peginterferon Lambda

Sep 12, 2023 04:05 PM Eiger to Discontinue Phase 3 LIMT-2 Trial of Peginterferon Lambda in Patients with Chronic Hepatitis Delta